B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide are comparably useful for disease monitoring in heart failure [5]

International Journal of Cardiology

Volumn 106, Issue 3, 2006, Pages 415-417

  Hammerer Lercher, Angelika ^a   Pölzl, Gerhard ^a   Falkensammer, Gerda ^a   Ludwig, Wilma ^a   Hügel, Heike ^a   Puschendorf, Bernd ^a   Pachinger, Otmar ^a   Mair, Johannes ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Disease monitoring; Heart failure; Natriuretic peptides

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; NEUROHORMONE;

ADULT; AGED; AMINO TERMINAL SEQUENCE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HEART FAILURE; HUMAN; LETTER; MALE; PRIORITY JOURNAL;

EID: 28844458286     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2005.01.016     Document Type: Article

References (8)

1. S.C. Lee, T.L. Stevens, and S.M. Sandberg The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failure J Card Fail 8 2002 149 154
2. P. Jourdain, F. Funck, and M. Bellorini Bedside B-type natriuretic peptide and functional capacity in chronic heart failure Eur J Heart Fail 5 2003 155 160
3. T. Tsutamoto, A. Wada, and K. Maeda Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure J Am Coll Cardiol 37 2001 1228 1233
4. M. Yoshimura, Y. Mizuno, and M. Nakayama B-type natriuretic peptide as a marker of the effects of enalapril in patients with heart failure Am J Med 112 2002 716 720
5. T. Kinugawa, S. Osaki, and M. Kato Effects of the angiotensin-converting enzyme inhibitor alacepril on exercise capacity and neurohormonal factors in patients with mild-to-moderate heart failure Clin Exp Pharmacol Physiol 29 2002 1060 1065
6. S.D. Ry, A. Clerico, and D. Giannessi Measurement of brain natriuretic peptide in plasma samples and cardiac tissue extracts by means of an immunoradiometric assay method Scand J Clin Lab Invest 60 2000 81 90
7. J. Karl, A. Borgya, A. Gallusser, E. Huber, K. Krueger, and W. Rollinger Development of a novel, N-terminal-proBNP (NT-proBNP) assay with a low detection limit Scand J Clin Lab Invest 59 1999 177 181
8. M.H. Zweig, and G. Campell Receiver-Operating Characteristics (ROC) Plots: a fundamental evaluation tool in clinical medicine Clin Chem 39 1993 561 577